|
Aardvark Therapeutics, Inc.
|
AARD
|
██%
|
$119M
|
x
|
1,4x
|
|
Abbvie Inc.
|
ABBV
|
██%
|
$356.57B
|
98,1x
|
x
|
|
Abcellera Biologics Inc.
|
ABCL
|
██%
|
$1.58B
|
x
|
1,6x
|
|
Abeona Therapeutics Inc.
|
ABEO
|
██%
|
$325M
|
4,6x
|
2,0x
|
|
Abbott Laboratories
|
ABT
|
██%
|
$146.87B
|
23,4x
|
2,8x
|
|
Arbutus Biopharma Corp
|
ABUS
|
██%
|
$836M
|
x
|
10,9x
|
|
Abvc Biopharma, Inc.
|
ABVC
|
██%
|
$27M
|
x
|
2,4x
|
|
Abivax S.A.
|
ABVX
|
██%
|
$9.64B
|
x
|
x
|
|
Acadia Pharmaceuticals Inc
|
ACAD
|
██%
|
$3.83B
|
10,2x
|
3,1x
|
|
Adicet Bio, Inc.
|
ACET
|
██%
|
$80M
|
x
|
0,5x
|
|
Aclaris Therapeutics, Inc.
|
ACRS
|
██%
|
$688M
|
x
|
4,8x
|
|
Acrivon Therapeutics, Inc.
|
ACRV
|
██%
|
$85M
|
x
|
0,8x
|
|
Actuate Therapeutics, Inc.
|
ACTU
|
██%
|
$120M
|
x
|
11,0x
|
|
Accustem Sciences Inc.
|
ACUT
|
██%
|
$4M
|
x
|
x
|
|
Acurx Pharmaceuticals, Inc.
|
ACXP
|
██%
|
$6M
|
x
|
1,1x
|
|
Adagene Inc.
|
ADAG
|
██%
|
$244M
|
x
|
6,4x
|
|
Adc Therapeutics Sa
|
ADCT
|
██%
|
$445M
|
x
|
x
|
|
Adial Pharmaceuticals, Inc.
|
ADIL
|
██%
|
$2M
|
x
|
0,4x
|
|
Aditxt, Inc.
|
ADTX
|
██%
|
$110K
|
x
|
0,0x
|
|
Addex Therapeutics Ltd.
|
ADXN
|
██%
|
$8M
|
x
|
x
|
|
Aeon Biopharma, Inc.
|
AEON
|
██%
|
$24M
|
x
|
x
|
|
Agios Pharmaceuticals, Inc.
|
AGIO
|
██%
|
$1.65B
|
x
|
1,5x
|
|
Akebia Therapeutics, Inc.
|
AKBA
|
██%
|
$311M
|
x
|
11,4x
|
|
Akero Therapeutics, Inc.
|
AKRO
|
██%
|
$4.38B
|
-8,7x
|
4,6x
|
|
Akari Therapeutics Plc
|
AKTX
|
██%
|
$7M
|
x
|
0,3x
|
|
Aldeyra Therapeutics, Inc.
|
ALDX
|
██%
|
$104M
|
x
|
2,5x
|
|
Alkermes Plc.
|
ALKS
|
██%
|
$5.82B
|
38,1x
|
3,3x
|
|
Allarity Therapeutics, Inc.
|
ALLR
|
██%
|
$25M
|
x
|
2,5x
|
|
Alumis Inc.
|
ALMS
|
██%
|
$3.01B
|
x
|
10,0x
|
|
Alnylam Pharmaceuticals, Inc.
|
ALNY
|
██%
|
$39.06B
|
124,5x
|
49,5x
|
|
Altimmune, Inc.
|
ALT
|
██%
|
$601M
|
x
|
2,7x
|
|
Alx Oncology Holdings Inc
|
ALXO
|
██%
|
$280M
|
x
|
1,9x
|
|
Alzamend Neuro, Inc.
|
ALZN
|
██%
|
$4M
|
x
|
1,9x
|
|
Amylyx Pharmaceuticals, Inc.
|
AMLX
|
██%
|
$1.64B
|
x
|
6,0x
|
|
Amphastar Pharmaceuticals, Inc.
|
AMPH
|
██%
|
$848M
|
10,7x
|
1,1x
|
|
Amarin Corp Plc\Uk
|
AMRN
|
██%
|
$316M
|
x
|
0,7x
|
|
Amneal Pharmaceuticals, Inc.
|
AMRX
|
██%
|
$4.17B
|
34,2x
|
x
|
|
Anaptysbio, Inc
|
ANAB
|
██%
|
$2.02B
|
x
|
54,2x
|
|
Anebulo Pharmaceuticals, Inc.
|
ANEB
|
██%
|
$21M
|
x
|
2,7x
|
|
Ani Pharmaceuticals Inc
|
ANIP
|
██%
|
$1.71B
|
18,6x
|
3,0x
|
|
Anixa Biosciences Inc
|
ANIX
|
██%
|
$100M
|
x
|
6,7x
|
|
Annexon, Inc.
|
ANNX
|
██%
|
$867M
|
x
|
4,2x
|
|
Alto Neuroscience, Inc.
|
ANRO
|
██%
|
$774M
|
x
|
5,1x
|
|
An2 Therapeutics, Inc.
|
ANTX
|
██%
|
$161M
|
x
|
3,0x
|
|
Annovis Bio, Inc.
|
ANVS
|
██%
|
$79M
|
x
|
4,7x
|
|
Apollomics Inc.
|
APLM
|
██%
|
$34M
|
x
|
x
|
|
Apellis Pharmaceuticals, Inc.
|
APLS
|
██%
|
$5.25B
|
39,4x
|
12,7x
|
|
Applied Therapeutics, Inc.
|
APLT
|
██%
|
$15M
|
-0,7x
|
0,9x
|
|
Aprea Therapeutics, Inc.
|
APRE
|
██%
|
$12M
|
x
|
1,0x
|
|
Apimeds Pharmaceuticals Us, Inc.
|
APUS
|
██%
|
$19M
|
x
|
2,3x
|
|
Aptevo Therapeutics Inc.
|
APVO
|
██%
|
$6M
|
x
|
0,3x
|
|
Aquestive Therapeutics, Inc.
|
AQST
|
██%
|
$527M
|
x
|
x
|
|
Arcturus Therapeutics Holdings Inc.
|
ARCT
|
██%
|
$262M
|
x
|
1,4x
|
|
Ardelyx, Inc.
|
ARDX
|
██%
|
$1.67B
|
x
|
11,3x
|
|
Arcutis Biotherapeutics, Inc.
|
ARQT
|
██%
|
$2.65B
|
x
|
14,0x
|
|
Artelo Biosciences, Inc.
|
ARTL
|
██%
|
$2M
|
x
|
x
|
|
Arvinas, Inc.
|
ARVN
|
██%
|
$642M
|
x
|
1,5x
|
|
Arrowhead Pharmaceuticals, Inc.
|
ARWR
|
██%
|
$10.22B
|
x
|
16,6x
|
|
Aspire Biopharma Holdings, Inc.
|
ASBP
|
██%
|
$930K
|
x
|
x
|
|
Assembly Biosciences, Inc.
|
ASMB
|
██%
|
$473M
|
x
|
2,4x
|
|
Ascendis Pharma A/S
|
ASND
|
██%
|
$14.79B
|
x
|
x
|
|
Assertio Holdings, Inc.
|
ASRT
|
██%
|
$145M
|
x
|
1,9x
|
|
Atai Beckley N.V.
|
ATAI
|
██%
|
$1.48B
|
x
|
9,3x
|
|
Alterity Therapeutics Ltd
|
ATHE
|
██%
|
$88M
|
x
|
x
|
|
Actinium Pharmaceuticals, Inc.
|
ATNM
|
██%
|
$41M
|
x
|
17,8x
|
|
Atossa Therapeutics, Inc.
|
ATOS
|
██%
|
$48M
|
x
|
1,6x
|
|
Avenue Therapeutics, Inc.
|
ATXI
|
██%
|
$2M
|
x
|
1,4x
|
|
Astria Therapeutics, Inc.
|
ATXS
|
██%
|
$710M
|
-4,7x
|
3,0x
|
|
Aurinia Pharmaceuticals Inc.
|
AUPH
|
██%
|
$1.99B
|
6,7x
|
3,5x
|
|
Arrivent Biopharma, Inc.
|
AVBP
|
██%
|
$1.25B
|
x
|
4,1x
|
|
Avadel Pharmaceuticals Plc
|
AVDL
|
██%
|
$2.10B
|
-10,2x
|
21,4x
|
|
Atea Pharmaceuticals, Inc.
|
AVIR
|
██%
|
$424M
|
x
|
1,5x
|
|
Avalo Therapeutics, Inc.
|
AVTX
|
██%
|
$1.13B
|
x
|
13,6x
|
|
Axim Biotechnologies, Inc.
|
AXIM
|
██%
|
$2M
|
x
|
x
|
|
Axsome Therapeutics, Inc.
|
AXSM
|
██%
|
$11.18B
|
x
|
204,8x
|
|
Aytu Biopharma, Inc
|
AYTU
|
██%
|
$27M
|
-0,3x
|
1,2x
|
|
Azitra, Inc.
|
AZTR
|
██%
|
$4M
|
x
|
1,0x
|
|
Bridgebio Pharma, Inc.
|
BBIO
|
██%
|
$13.19B
|
x
|
x
|
|
Bridgebio Oncology Therapeutics, Inc.
|
BBOT
|
██%
|
$613M
|
x
|
1,5x
|
|
Bicara Therapeutics Inc.
|
BCAX
|
██%
|
$1.48B
|
x
|
3,7x
|
|
Briacell Therapeutics Corp.
|
BCTX
|
██%
|
$30M
|
x
|
1,0x
|
|
Bicycle Therapeutics Plc
|
BCYC
|
██%
|
$335M
|
x
|
0,6x
|
|
Bioadaptives, Inc.
|
BDPT
|
██%
|
$130K
|
x
|
x
|
|
Biodexa Pharmaceuticals Plc
|
BDRX
|
██%
|
$510K
|
x
|
x
|
|
Beone Medicines Ltd.
|
BEIGF
|
██%
|
$36.38B
|
530,6x
|
8,8x
|
|
Bullfrog Ai Holdings, Inc.
|
BFRG
|
██%
|
$12M
|
x
|
5,7x
|
|
Biofrontera Inc.
|
BFRI
|
██%
|
$13M
|
x
|
1,3x
|
|
Bio Green Med Solution, Inc.
|
BGMS
|
██%
|
$5M
|
x
|
0,7x
|
|
Bausch Health Companies Inc.
|
BHC
|
██%
|
$2.15B
|
x
|
x
|
|
Bioharvest Sciences Inc.
|
BHST
|
██%
|
$90M
|
x
|
3,5x
|
|
Biohaven Ltd.
|
BHVN
|
██%
|
$1.22B
|
-4,6x
|
23,4x
|
|
Bioage Labs, Inc.
|
BIOA
|
██%
|
$799M
|
x
|
2,1x
|
|
Bio Essence Corp
|
BIOE
|
██%
|
$19M
|
21,2x
|
x
|
|
Biovie Inc.
|
BIVI
|
██%
|
$11M
|
x
|
0,6x
|
|
Bioxytran, Inc
|
BIXT
|
██%
|
$4M
|
x
|
x
|
|
Biolinerx Ltd.
|
BLRX
|
██%
|
$14M
|
x
|
x
|
|
Belite Bio, Inc
|
BLTE
|
██%
|
$6.09B
|
x
|
7,9x
|
|
Biomea Fusion, Inc.
|
BMEA
|
██%
|
$111M
|
x
|
3,8x
|
|
Biomarin Pharmaceutical Inc
|
BMRN
|
██%
|
$10.45B
|
38,9x
|
1,7x
|
|
Bristol Myers Squibb Co
|
BMY
|
██%
|
$114.45B
|
15,7x
|
5,7x
|
|
Bristol Myers Squibb Co
|
BMYMP
|
██%
|
$1.73T
|
287,0x
|
93,4x
|
|
Benitec Biopharma Inc.
|
BNTC
|
██%
|
$421M
|
x
|
2,3x
|
|
Boundless Bio, Inc.
|
BOLD
|
██%
|
$32M
|
x
|
0,4x
|
|
Bolt Biotherapeutics, Inc.
|
BOLT
|
██%
|
$9M
|
x
|
0,3x
|
|
Bio-Path Holdings, Inc.
|
BPTH
|
██%
|
$460K
|
x
|
x
|
|
Bioquest Corp
|
BQST
|
██%
|
$2M
|
x
|
x
|
|
Barinthus Biotherapeutics Plc.
|
BRNS
|
██%
|
$27M
|
x
|
0,4x
|
|
Bespoke Extracts, Inc.
|
BSPK
|
██%
|
$2M
|
x
|
x
|
|
Bioxcel Therapeutics, Inc.
|
BTAI
|
██%
|
$33M
|
x
|
x
|
|
Beyondspring Inc.
|
BYSI
|
██%
|
$60M
|
x
|
x
|
|
Calcimedica, Inc.
|
CALC
|
██%
|
$10M
|
x
|
x
|
|
Camp4 Therapeutics Corp
|
CAMP
|
██%
|
$208M
|
-0,1x
|
4,4x
|
|
Can-Fite Biopharma Ltd.
|
CANF
|
██%
|
$8M
|
x
|
1,3x
|
|
Capricor Therapeutics, Inc.
|
CAPR
|
██%
|
$1.74B
|
x
|
5,7x
|
|
Carisma Therapeutics Inc.
|
CARM
|
██%
|
$20K
|
0,0x
|
x
|
|
Casi Pharmaceuticals, Inc.
|
CASI
|
██%
|
$5M
|
-1,4x
|
2,5x
|
|
Perspective Therapeutics, Inc.
|
CATX
|
██%
|
$429M
|
x
|
2,1x
|
|
Gyre Therapeutics, Inc.
|
CBIO
|
██%
|
$517M
|
x
|
5,1x
|
|
Cdt Equity Inc.
|
CDT
|
██%
|
$10M
|
x
|
2,3x
|
|
Cingulate Inc.
|
CING
|
██%
|
$65M
|
x
|
25,7x
|
|
Cell Source, Inc.
|
CLCS
|
██%
|
$56M
|
x
|
x
|
|
Clene Inc.
|
CLNN
|
██%
|
$79M
|
x
|
x
|
|
Cellectar Biosciences, Inc.
|
CLRB
|
██%
|
$13M
|
x
|
1,5x
|
|
Clearside Biomedical, Inc.
|
CLSD
|
██%
|
$4M
|
-2,0x
|
-0,7x
|
|
Clearside Biomedical, Inc.
|
CLSDQ
|
██%
|
$2M
|
x
|
x
|
|
Climb Bio, Inc.
|
CLYM
|
██%
|
$543M
|
x
|
3,7x
|
|
Chemomab Therapeutics Ltd.
|
CMMB
|
██%
|
$13M
|
x
|
1,0x
|
|
Clearmind Medicine Inc.
|
CMND
|
██%
|
$6M
|
x
|
x
|
|
Compass Pathways Plc
|
CMPS
|
██%
|
$1.34B
|
x
|
x
|
|
Cnbx Pharmaceuticals Inc.
|
CNBX
|
██%
|
$110K
|
x
|
x
|
|
Cns Pharmaceuticals, Inc.
|
CNSP
|
██%
|
$6M
|
x
|
1,3x
|
|
Centessa Pharmaceuticals Plc
|
CNTA
|
██%
|
$6.13B
|
x
|
12,6x
|
|
Connect Biopharma Holdings Ltd
|
CNTB
|
██%
|
$133M
|
x
|
3,2x
|
|
Canton Strategic Holdings, Inc.
|
CNTN
|
██%
|
$171M
|
x
|
0,4x
|
|
Context Therapeutics Inc.
|
CNTX
|
██%
|
$219M
|
x
|
4,2x
|
|
Cocrystal Pharma, Inc.
|
COCP
|
██%
|
$20M
|
x
|
3,1x
|
|
Cogent Biosciences, Inc.
|
COGT
|
██%
|
$5.93B
|
x
|
9,8x
|
|
Collegium Pharmaceutical, Inc
|
COLL
|
██%
|
$1.22B
|
16,3x
|
3,9x
|
|
Corcept Therapeutics Inc
|
CORT
|
██%
|
$5.46B
|
115,3x
|
8,6x
|
|
Coya Therapeutics, Inc.
|
COYA
|
██%
|
$96M
|
x
|
2,2x
|
|
China Pharma Holdings, Inc.
|
CPHI
|
██%
|
$21M
|
x
|
2,6x
|
|
Cumberland Pharmaceuticals Inc
|
CPIX
|
██%
|
$70M
|
x
|
3,2x
|
|
Cannapharmarx, Inc.
|
CPMD
|
██%
|
$2M
|
x
|
x
|
|
Catalyst Pharmaceuticals, Inc.
|
CPRX
|
██%
|
$3.81B
|
17,8x
|
4,0x
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
CRBP
|
██%
|
$193M
|
x
|
1,3x
|
|
Cormedix Inc.
|
CRMD
|
██%
|
$628M
|
3,9x
|
1,6x
|
|
Crinetics Pharmaceuticals, Inc.
|
CRNX
|
██%
|
$3.95B
|
x
|
3,1x
|
|
Cervomed Inc.
|
CRVO
|
██%
|
$37M
|
x
|
2,0x
|
|
Corvus Pharmaceuticals, Inc.
|
CRVS
|
██%
|
$1.31B
|
x
|
5,4x
|
|
Cytomx Therapeutics, Inc.
|
CTMX
|
██%
|
$866M
|
x
|
2,7x
|
|
Contineum Therapeutics, Inc.
|
CTNM
|
██%
|
$543M
|
x
|
2,2x
|
|
Citius Oncology, Inc.
|
CTOR
|
██%
|
$77M
|
x
|
1,3x
|
|
Hepion Pharmaceuticals, Inc.
|
CTRVP
|
██%
|
$20K
|
x
|
0,0x
|
|
Ctt Pharmaceutical Holdings, Inc.
|
CTTH
|
██%
|
$4M
|
x
|
5,6x
|
|
Citius Pharmaceuticals, Inc.
|
CTXR
|
██%
|
$18M
|
x
|
0,2x
|
|
Cue Biopharma, Inc.
|
CUE
|
██%
|
$114M
|
x
|
4,3x
|
|
Curanex Pharmaceuticals Inc
|
CURX
|
██%
|
$9M
|
x
|
0,8x
|
|
Cadrenal Therapeutics, Inc.
|
CVKD
|
██%
|
$19M
|
x
|
10,4x
|
|
Cv Sciences, Inc.
|
CVSI
|
██%
|
$6M
|
x
|
3,8x
|
|
Cyclerion Therapeutics, Inc.
|
CYCN
|
██%
|
$13M
|
x
|
1,5x
|
|
Cytodyn Inc.
|
CYDY
|
██%
|
$448M
|
x
|
x
|
|
Cypherpunk Technologies Inc.
|
CYPH
|
██%
|
$116M
|
24,1x
|
0,8x
|
|
Cryoport, Inc.
|
CYRX
|
██%
|
$683M
|
8,6x
|
1,4x
|
|
Cytokinetics Inc
|
CYTK
|
██%
|
$10.33B
|
x
|
x
|
|
Dare Bioscience, Inc.
|
DARE
|
██%
|
$40M
|
x
|
14,0x
|
|
Day One Biopharmaceuticals, Inc.
|
DAWN
|
██%
|
$2.22B
|
x
|
5,0x
|
|
Decoy Therapeutics Inc.
|
DCOY
|
██%
|
$3M
|
x
|
0,8x
|
|
Journey Medical Corp
|
DERM
|
██%
|
$139M
|
x
|
4,4x
|
|
Diamedica Therapeutics Inc.
|
DMAC
|
██%
|
$341M
|
x
|
7,2x
|
|
Damora Therapeutics, Inc.
|
DMRA
|
██%
|
$1.46B
|
x
|
6,1x
|
|
Dianthus Therapeutics, Inc. /De/
|
DNTH
|
██%
|
$4.73B
|
x
|
3,9x
|
|
Dermata Therapeutics, Inc.
|
DRMA
|
██%
|
$5M
|
x
|
0,8x
|
|
Bright Minds Biosciences Inc.
|
DRUG
|
██%
|
$837M
|
x
|
x
|
|
Design Therapeutics, Inc.
|
DSGN
|
██%
|
$888M
|
x
|
4,1x
|
|
Dynavax Technologies Corp
|
DVAX
|
██%
|
$1.82B
|
88,2x
|
3,4x
|
|
Dogwood Therapeutics, Inc.
|
DWTX
|
██%
|
$55M
|
x
|
0,7x
|
|
Dyne Therapeutics, Inc.
|
DYN
|
██%
|
$2.90B
|
x
|
3,0x
|
|
Emergent Biosolutions Inc.
|
EBS
|
██%
|
$492M
|
x
|
0,9x
|
|
Edesa Biotech, Inc.
|
EDSA
|
██%
|
$136M
|
x
|
9,7x
|
|
Eagle Pharmaceuticals, Inc.
|
EGRX
|
██%
|
$4M
|
0,4x
|
0,0x
|
|
Pmgc Holdings Inc.
|
ELAB
|
██%
|
$9M
|
x
|
1,1x
|
|
Elanco Animal Health Inc
|
ELAN
|
██%
|
$11.81B
|
x
|
1,8x
|
|
Eledon Pharmaceuticals, Inc.
|
ELDN
|
██%
|
$293M
|
x
|
3,6x
|
|
Elite Pharmaceuticals Inc /Nv/
|
ELTP
|
██%
|
$376M
|
13,7x
|
4,7x
|
|
Elicio Therapeutics, Inc.
|
ELTX
|
██%
|
$185M
|
x
|
113,3x
|
|
Enliven Therapeutics, Inc.
|
ELVN
|
██%
|
$2.48B
|
x
|
5,5x
|
|
Emmaus Life Sciences, Inc.
|
EMMA
|
██%
|
$700K
|
x
|
x
|
|
Enlivex Ltd.
|
ENLV
|
██%
|
$186M
|
0,1x
|
0,1x
|
|
Ensysce Biosciences, Inc.
|
ENSC
|
██%
|
$3M
|
x
|
1,0x
|
|
Enanta Pharmaceuticals Inc
|
ENTA
|
██%
|
$445M
|
x
|
3,5x
|
|
Gridai Technologies Corp.
|
ENTO
|
██%
|
$7M
|
0,0x
|
0,3x
|
|
Enveric Biosciences, Inc.
|
ENVB
|
██%
|
$6M
|
x
|
1,4x
|
|
Evolus, Inc.
|
EOLS
|
██%
|
$419M
|
x
|
x
|
|
Essa Pharma Inc.
|
EPIX
|
██%
|
$9M
|
-2,7x
|
0,1x
|
|
Eupraxia Pharmaceuticals Inc.
|
EPRX
|
██%
|
$458M
|
x
|
5,6x
|
|
Equillium, Inc.
|
EQ
|
██%
|
$130M
|
x
|
4,5x
|
|
Erasca, Inc.
|
ERAS
|
██%
|
$2.88B
|
x
|
8,8x
|
|
Ernexa Therapeutics Inc.
|
ERNA
|
██%
|
$9M
|
x
|
3,7x
|
|
Esperion Therapeutics, Inc.
|
ESPR
|
██%
|
$789M
|
x
|
x
|
|
89bio, Inc.
|
ETNB
|
██%
|
$2.20B
|
-3,5x
|
4,2x
|
|
Eton Pharmaceuticals, Inc.
|
ETON
|
██%
|
$802M
|
x
|
30,7x
|
|
Earth Science Tech, Inc.
|
ETST
|
██%
|
$51M
|
12,6x
|
8,9x
|
|
Evofem Biosciences, Inc.
|
EVFM
|
██%
|
$810K
|
2,1x
|
x
|
|
Evommune, Inc.
|
EVMN
|
██%
|
$826M
|
x
|
2,7x
|
|
Edgewise Therapeutics, Inc.
|
EWTX
|
██%
|
$3.80B
|
x
|
7,7x
|
|
Fuss Brands Corp.
|
FBDS
|
██%
|
$2M
|
x
|
0,0x
|
|
Fortress Biotech, Inc.
|
FBIO
|
██%
|
$75M
|
11,0x
|
1,5x
|
|
Fortress Biotech, Inc.
|
FBIOP
|
██%
|
$394M
|
98,8x
|
7,1x
|
|
Fibrobiologics, Inc.
|
FBLG
|
██%
|
$6M
|
x
|
2,3x
|
|
Forte Biosciences, Inc.
|
FBRX
|
██%
|
$492M
|
x
|
8,1x
|
|
Fibrogen Inc
|
FGEN
|
██%
|
$35M
|
0,2x
|
-3,6x
|
|
Foghorn Therapeutics Inc.
|
FHTX
|
██%
|
$261M
|
x
|
x
|
|
Filana Therapeutics, Inc.
|
FLNA
|
██%
|
$63M
|
x
|
0,9x
|
|
Amicus Therapeutics, Inc.
|
FOLD
|
██%
|
$4.50B
|
x
|
16,4x
|
|
Fulcrum Therapeutics, Inc.
|
FULC
|
██%
|
$467M
|
x
|
1,4x
|
|
Galectin Therapeutics Inc
|
GALT
|
██%
|
$137M
|
x
|
x
|
|
Gain Therapeutics, Inc.
|
GANX
|
██%
|
$77M
|
x
|
4,1x
|
|
Generation Bio Co.
|
GBIO
|
██%
|
$36M
|
-0,6x
|
0,7x
|
|
Greater Cannabis Company, Inc.
|
GCAN
|
██%
|
$190K
|
x
|
x
|
|
Cytomed Therapeutics Ltd
|
GDTC
|
██%
|
$9M
|
x
|
x
|
|
Geron Corp
|
GERN
|
██%
|
$907M
|
x
|
4,0x
|
|
Gh Research Plc
|
GHRS
|
██%
|
$1.33B
|
x
|
x
|
|
Galmed Pharmaceuticals Ltd.
|
GLMD
|
██%
|
$4M
|
x
|
0,3x
|
|
Lakefront Biotherapeutics Nv
|
GLPG
|
██%
|
$1.88B
|
x
|
x
|
|
Greenwich Lifesciences, Inc.
|
GLSI
|
██%
|
$315M
|
x
|
144,3x
|
|
Galecto, Inc.
|
GLTO
|
██%
|
$1.59B
|
-2,5x
|
198,2x
|
|
Genelux Corp
|
GNLX
|
██%
|
$139M
|
x
|
6,1x
|
|
Genprex, Inc.
|
GNPX
|
██%
|
$9M
|
x
|
1,1x
|
|
Gossamer Bio, Inc.
|
GOSS
|
██%
|
$76M
|
x
|
x
|
|
Geovax Labs, Inc.
|
GOVX
|
██%
|
$5M
|
x
|
1,0x
|
|
Structure Therapeutics Inc.
|
GPCR
|
██%
|
$2.78B
|
x
|
1,9x
|
|
Grace Therapeutics, Inc.
|
GRCE
|
██%
|
$36M
|
x
|
0,6x
|
|
Gridai Technologies Corp.
|
GRDX
|
██%
|
$21M
|
x
|
0,9x
|
|
Gri Bio, Inc.
|
GRI
|
██%
|
$3M
|
x
|
0,5x
|
|
Galera Therapeutics, Inc.
|
GRTX
|
██%
|
$16M
|
0,1x
|
4,0x
|
|
Gsk Plc
|
GSK
|
██%
|
$101.20B
|
x
|
x
|
|
Gt Biopharma, Inc.
|
GTBP
|
██%
|
$13M
|
x
|
2,3x
|
|
Gyre Therapeutics, Inc.
|
GYRE
|
██%
|
$682M
|
x
|
6,7x
|
|
Hutchmed (China) Ltd
|
HCM
|
██%
|
$2.26B
|
2,5x
|
1,8x
|
|
Hcw Biologics Inc.
|
HCWB
|
██%
|
$2M
|
x
|
0,8x
|
|
Cybin Inc.
|
HELP
|
██%
|
$265M
|
x
|
x
|
|
Hepion Pharmaceuticals, Inc.
|
HEPA
|
██%
|
$2M
|
x
|
0,6x
|
|
Vyome Holdings, Inc
|
HIND
|
██%
|
$14M
|
x
|
5,9x
|
|
Hutchmed (China) Ltd
|
HMDCF
|
██%
|
$2.64B
|
x
|
2,1x
|
|
Hookipa Pharma Inc.
|
HOOK
|
██%
|
$15M
|
x
|
0,4x
|
|
Hoth Therapeutics, Inc.
|
HOTH
|
██%
|
$13M
|
x
|
2,1x
|
|
Werewolf Therapeutics, Inc.
|
HOWL
|
██%
|
$33M
|
x
|
2,7x
|
|
Harmony Biosciences Holdings, Inc.
|
HRMY
|
██%
|
$1.79B
|
12,3x
|
2,0x
|
|
Heron Therapeutics, Inc. /De/
|
HRTX
|
██%
|
$228M
|
x
|
15,9x
|
|
Hst Global, Inc.
|
HSTC
|
██%
|
$88M
|
x
|
71,3x
|
|
Tuhura Biosciences, Inc./Nv
|
HURA
|
██%
|
$152M
|
x
|
7,2x
|
|
Mindwalk Holdings Corp.
|
HYFT
|
██%
|
$59M
|
x
|
x
|
|
Hyperion Defi, Inc.
|
HYPD
|
██%
|
$41M
|
x
|
1,0x
|
|
Ibio, Inc.
|
IBIO
|
██%
|
$62M
|
x
|
1,1x
|
|
Impact Biomedical Inc.
|
IBO
|
██%
|
$68M
|
x
|
5,4x
|
|
Ideaya Biosciences, Inc.
|
IDYA
|
██%
|
$2.49B
|
x
|
2,7x
|
|
Inflarx N.V.
|
IFRX
|
██%
|
$187M
|
x
|
x
|
|
Igc Pharma, Inc.
|
IGC
|
██%
|
$29M
|
x
|
4,0x
|
|
Immutep Ltd
|
IMMP
|
██%
|
$66M
|
x
|
x
|
|
Immix Biopharma, Inc.
|
IMMX
|
██%
|
$517M
|
x
|
6,1x
|
|
Immunome Inc.
|
IMNM
|
██%
|
$2.54B
|
x
|
4,0x
|
|
Imunon, Inc.
|
IMNN
|
██%
|
$11M
|
x
|
1,5x
|
|
Immuron Ltd
|
IMRN
|
██%
|
$7M
|
x
|
x
|
|
Immuneering Corp
|
IMRX
|
██%
|
$338M
|
x
|
1,6x
|
|
Eom Pharmaceutical Holdings, Inc.
|
IMUC
|
██%
|
$6M
|
x
|
1,8x
|
|
Immunic, Inc.
|
IMUX
|
██%
|
$158M
|
x
|
x
|
|
Integrated Biopharma Inc
|
INBP
|
██%
|
$8M
|
x
|
0,4x
|
|
Indaptus Therapeutics, Inc.
|
INDP
|
██%
|
$4M
|
x
|
1,3x
|
|
Indivior Pharmaceuticals, Inc.
|
INDV
|
██%
|
$4.90B
|
19,4x
|
x
|
|
Inmed Pharmaceuticals Inc.
|
INM
|
██%
|
$2M
|
x
|
0,3x
|
|
Inovio Pharmaceuticals, Inc.
|
INO
|
██%
|
$119M
|
x
|
4,9x
|
|
Insmed Inc
|
INSM
|
██%
|
$21.94B
|
x
|
31,1x
|
|
Inhibitor Therapeutics, Inc.
|
INTI
|
██%
|
$14M
|
x
|
x
|
|
Innoviva, Inc.
|
INVA
|
██%
|
$1.69B
|
3,4x
|
1,3x
|
|
Io Biotech, Inc.
|
IOBT
|
██%
|
$540K
|
x
|
0,6x
|
|
Io Biotech, Inc.
|
IOBTQ
|
██%
|
$280K
|
x
|
0,3x
|
|
Ionis Pharmaceuticals Inc
|
IONS
|
██%
|
$12.56B
|
x
|
25,6x
|
|
Opus Genetics, Inc.
|
IRD
|
██%
|
$349M
|
x
|
22,7x
|
|
Disc Medicine, Inc.
|
IRON
|
██%
|
$2.61B
|
x
|
3,8x
|
|
Ironwood Pharmaceuticals Inc
|
IRWD
|
██%
|
$695M
|
6,8x
|
x
|
|
International Stem Cell Corp
|
ISCO
|
██%
|
$1M
|
x
|
x
|
|
Iterum Therapeutics Plc
|
ITRM
|
██%
|
$1M
|
x
|
x
|
|
Inventiva S.A.
|
IVA
|
██%
|
$1.12B
|
x
|
x
|
|
Incannex Healthcare Inc.
|
IXHL
|
██%
|
$64M
|
x
|
0,9x
|
|
Jaguar Health, Inc.
|
JAGX
|
██%
|
$1M
|
x
|
0,2x
|
|
Janux Therapeutics, Inc.
|
JANX
|
██%
|
$863M
|
x
|
0,9x
|
|
Jazz Pharmaceuticals Plc
|
JAZZ
|
██%
|
$13.98B
|
473,9x
|
3,1x
|
|
Jade Biosciences, Inc.
|
JBIO
|
██%
|
$1.27B
|
x
|
4,3x
|
|
Johnson & Johnson
|
JNJ
|
██%
|
$533.09B
|
25,3x
|
6,6x
|
|
Jupiter Neurosciences, Inc.
|
JUNS
|
██%
|
$12M
|
x
|
210,4x
|
|
Kala Bio, Inc.
|
KALA
|
██%
|
$1M
|
x
|
x
|
|
Kalvista Pharmaceuticals, Inc.
|
KALV
|
██%
|
$1.37B
|
x
|
x
|
|
Kairos Pharma, Ltd.
|
KAPA
|
██%
|
$12M
|
x
|
1,8x
|
|
Kaya Holdings, Inc.
|
KAYS
|
██%
|
$23M
|
x
|
x
|
|
Kamada Ltd
|
KMDA
|
██%
|
$493M
|
x
|
x
|
|
Kiniksa Pharmaceuticals International, Plc
|
KNSA
|
██%
|
$4.48B
|
61,4x
|
7,4x
|
|
Kiora Pharmaceuticals Inc
|
KPRX
|
██%
|
$7M
|
-2,4x
|
0,3x
|
|
Karyopharm Therapeutics Inc.
|
KPTI
|
██%
|
$195M
|
x
|
x
|
|
Keros Therapeutics, Inc.
|
KROS
|
██%
|
$236M
|
2,7x
|
0,8x
|
|
Korro Bio, Inc.
|
KRRO
|
██%
|
$174M
|
x
|
1,5x
|
|
Pasithea Therapeutics Corp.
|
KTTA
|
██%
|
$18M
|
x
|
0,3x
|
|
Kura Oncology, Inc.
|
KURA
|
██%
|
$828M
|
x
|
4,8x
|
|
Kyntra Bio, Inc.
|
KYNB
|
██%
|
$28M
|
0,2x
|
x
|
|
Kezar Life Sciences, Inc.
|
KZR
|
██%
|
$54M
|
x
|
0,8x
|
|
Lb Pharmaceuticals Inc
|
LBRX
|
██%
|
$917M
|
x
|
3,0x
|
|
Legend Biotech Corp
|
LEGN
|
██%
|
$5.20B
|
x
|
x
|
|
Lexaria Bioscience Corp.
|
LEXX
|
██%
|
$15M
|
x
|
2,3x
|
|
Lifecore Biomedical, Inc. \De\
|
LFCR
|
██%
|
$180M
|
x
|
x
|
|
Lifevantage Corp
|
LFVN
|
██%
|
$67M
|
8,5x
|
2,0x
|
|
Ligand Pharmaceuticals Inc
|
LGND
|
██%
|
$2.69B
|
17,5x
|
2,7x
|
|
Longeveron Inc.
|
LGVN
|
██%
|
$25M
|
x
|
4,4x
|
|
Lianbio
|
LIANY
|
██%
|
$15M
|
x
|
0,1x
|
|
Lftd Partners Inc.
|
LIFD
|
██%
|
$3M
|
35,7x
|
0,1x
|
|
Lipella Pharmaceuticals Inc.
|
LIPO
|
██%
|
$140K
|
x
|
0,1x
|
|
Lite Strategy, Inc.
|
LITS
|
██%
|
$46M
|
x
|
0,6x
|
|
Lixte Biotechnology Holdings, Inc.
|
LIXT
|
██%
|
$60M
|
x
|
6,2x
|
|
Lixte Biotechnology Holdings, Inc.
|
LIXTW
|
██%
|
$130K
|
x
|
0,0x
|
|
Eli Lilly & Co
|
LLY
|
██%
|
$848.39B
|
33,6x
|
27,2x
|
|
Lunai Bioworks Inc.
|
LNAI
|
██%
|
$12M
|
7,4x
|
x
|
|
Lipocine Inc.
|
LPCN
|
██%
|
$18M
|
x
|
0,8x
|
|
Cypherpunk Technologies Inc.
|
LPTX
|
██%
|
$94M
|
-1,1x
|
35,1x
|
|
Liquidia Corp
|
LQDA
|
██%
|
$3.69B
|
x
|
82,4x
|
|
Larimar Therapeutics, Inc.
|
LRMR
|
██%
|
$412M
|
x
|
5,3x
|
|
Lisata Therapeutics, Inc.
|
LSTA
|
██%
|
$29M
|
x
|
1,9x
|
|
Lantern Pharma Inc.
|
LTRN
|
██%
|
$24M
|
x
|
3,6x
|
|
Lava Therapeutics Nv
|
LVTX
|
██%
|
$46M
|
x
|
3,6x
|
|
Lexicon Pharmaceuticals, Inc.
|
LXRX
|
██%
|
$851M
|
x
|
4,2x
|
|
Lyell Immunopharma, Inc.
|
LYEL
|
██%
|
$451M
|
x
|
1,7x
|
|
Maia Biotechnology, Inc.
|
MAIA
|
██%
|
$80M
|
x
|
33,7x
|
|
Mustang Bio, Inc.
|
MBIO
|
██%
|
$5M
|
x
|
0,6x
|
|
Moleculin Biotech, Inc.
|
MBRX
|
██%
|
$13M
|
x
|
0,9x
|
|
Mbx Biosciences, Inc.
|
MBX
|
██%
|
$1.95B
|
x
|
4,5x
|
|
Seres Therapeutics, Inc.
|
MCRB
|
██%
|
$74M
|
x
|
2,8x
|
|
Medicus Pharma Ltd.
|
MDCX
|
██%
|
$18M
|
x
|
x
|
|
Medicus Pharma Ltd.
|
MDCXW
|
██%
|
$52M
|
x
|
x
|
|
Madrigal Pharmaceuticals, Inc.
|
MDGL
|
██%
|
$11.75B
|
x
|
21,6x
|
|
Chrome Holding Co.
|
MEHCQ
|
██%
|
$96M
|
x
|
x
|
|
Macrogenics Inc
|
MGNX
|
██%
|
$190M
|
x
|
3,4x
|
|
Mira Pharmaceuticals, Inc.
|
MIRA
|
██%
|
$41M
|
x
|
4,0x
|
|
Mirum Pharmaceuticals, Inc.
|
MIRM
|
██%
|
$6.53B
|
x
|
26,9x
|
|
Milestone Pharmaceuticals Inc.
|
MIST
|
██%
|
$230M
|
x
|
5,5x
|
|
Moonlake Immunotherapeutics
|
MLTX
|
██%
|
$1.24B
|
x
|
4,1x
|
|
Mineralys Therapeutics, Inc.
|
MLYS
|
██%
|
$2.44B
|
x
|
3,8x
|
|
Mannkind Corp
|
MNKD
|
██%
|
$1.09B
|
x
|
x
|
|
Medicinova Inc
|
MNOV
|
██%
|
$69M
|
x
|
1,7x
|
|
Monopar Therapeutics
|
MNPR
|
██%
|
$425M
|
x
|
3,1x
|
|
Maplight Therapeutics, Inc.
|
MPLT
|
██%
|
$1.17B
|
x
|
2,6x
|
|
Mereo Biopharma Group Plc
|
MREO
|
██%
|
$40M
|
x
|
1,0x
|
|
Merck & Co., Inc.
|
MRK
|
██%
|
$275.33B
|
30,8x
|
6,0x
|
|
Marker Therapeutics, Inc.
|
MRKR
|
██%
|
$24M
|
x
|
1,5x
|
|
Mersana Therapeutics, Inc.
|
MRSN
|
██%
|
$145M
|
-3,4x
|
-1,4x
|
|
Merus N.V.
|
MRUS
|
██%
|
$6.83B
|
-13,5x
|
8,8x
|
|
Maravai Lifesciences Holdings, Inc.
|
MRVI
|
██%
|
$1.79B
|
x
|
8,5x
|
|
Matinas Biopharma Holdings, Inc.
|
MTNB
|
██%
|
$4M
|
x
|
1,4x
|
|
Metsera, Inc.
|
MTSR
|
██%
|
$7.41B
|
x
|
22,0x
|
|
Metavia Inc.
|
MTVA
|
██%
|
$6M
|
x
|
1,1x
|
|
Mural Oncology Plc
|
MURA
|
██%
|
$35M
|
x
|
0,6x
|
|
Mainz Biomed N.V.
|
MYNZ
|
██%
|
$7M
|
x
|
x
|
|
Newamsterdam Pharma Co N.V.
|
NAMS
|
██%
|
$4.52B
|
x
|
6,8x
|
|
Newamsterdam Pharma Co N.V.
|
NAMSW
|
██%
|
$2.59B
|
x
|
3,6x
|
|
Natures Sunshine Products Inc
|
NATR
|
██%
|
$426M
|
21,4x
|
2,6x
|
|
Novabridge Biosciences
|
NBP
|
██%
|
$254M
|
x
|
1,0x
|
|
Nanobiotix S.A.
|
NBTX
|
██%
|
$1.49B
|
x
|
x
|
|
Stablecoin Development Corp
|
NBY
|
██%
|
$37M
|
x
|
x
|
|
Newcelx Ltd.
|
NCEL
|
██%
|
$18M
|
x
|
33,1x
|
|
Nucana Plc
|
NCNA
|
██%
|
$9M
|
x
|
x
|
|
Minerva Neurosciences, Inc.
|
NERV
|
██%
|
$258M
|
x
|
x
|
|
Neuphoria Therapeutics Inc.
|
NEUP
|
██%
|
$29M
|
x
|
1,0x
|
|
Neurogene Inc.
|
NGNE
|
██%
|
$477M
|
x
|
1,8x
|
|
Nika Pharmaceuticals, Inc
|
NIKA
|
██%
|
$421M
|
x
|
x
|
|
Nektar Therapeutics
|
NKTR
|
██%
|
$2.76B
|
x
|
4,8x
|
|
Nkarta, Inc.
|
NKTX
|
██%
|
$227M
|
x
|
0,7x
|
|
Newcelx Ltd.
|
NLSP
|
██%
|
$54M
|
x
|
98,9x
|
|
Newcelx Ltd.
|
NLSPW
|
██%
|
$120K
|
x
|
0,2x
|
|
Nanoviricides, Inc.
|
NNVC
|
██%
|
$33M
|
x
|
3,0x
|
|
Nurix Therapeutics, Inc.
|
NRIX
|
██%
|
$1.71B
|
x
|
3,6x
|
|
Neurosense Therapeutics Ltd.
|
NRSN
|
██%
|
$32M
|
x
|
x
|
|
Nrx Pharmaceuticals, Inc.
|
NRXP
|
██%
|
$98M
|
x
|
x
|
|
Neonc Technologies Holdings, Inc.
|
NTHI
|
██%
|
$138M
|
x
|
x
|
|
Nuvation Bio Inc.
|
NUVB
|
██%
|
$1.66B
|
x
|
5,2x
|
|
Nuvalent, Inc.
|
NUVL
|
██%
|
$8.28B
|
x
|
7,1x
|
|
Nuvectis Pharma, Inc.
|
NVCT
|
██%
|
$309M
|
x
|
21,7x
|
|
Novartis Ag
|
NVS
|
██%
|
$278.65B
|
x
|
x
|
|
Northwest Biotherapeutics Inc
|
NWBO
|
██%
|
$370M
|
x
|
x
|
|
Nexien Biopharma, Inc.
|
NXEN
|
██%
|
$10K
|
x
|
x
|
|
Nextcure, Inc.
|
NXTC
|
██%
|
$35M
|
x
|
1,3x
|
|
Nexentis Technologies Inc.
|
NXTS
|
██%
|
$4M
|
x
|
0,2x
|
|
Ocean Biomedical, Inc.
|
OCEA
|
██%
|
$190K
|
-0,3x
|
0,1x
|
|
Ocular Therapeutix, Inc
|
OCUL
|
██%
|
$2.11B
|
x
|
3,6x
|
|
Oragenics Inc
|
OGEN
|
██%
|
$3M
|
x
|
0,4x
|
|
Organigram Global Inc.
|
OGI
|
██%
|
$191M
|
x
|
x
|
|
Organon & Co.
|
OGN
|
██%
|
$3.51B
|
14,3x
|
3,9x
|
|
Onkure Therapeutics, Inc.
|
OKUR
|
██%
|
$158M
|
x
|
0,9x
|
|
Olema Pharmaceuticals, Inc.
|
OLMA
|
██%
|
$1.21B
|
x
|
2,5x
|
|
Omeros Corp
|
OMER
|
██%
|
$1.01B
|
x
|
x
|
|
Beone Medicines Ltd.
|
ONC
|
██%
|
$32.38B
|
63,1x
|
6,8x
|
|
Onconetix, Inc.
|
ONCO
|
██%
|
$4M
|
x
|
0,3x
|
|
Oncolytics Biotech Inc
|
ONCY
|
██%
|
$103M
|
x
|
x
|
|
Opko Health, Inc.
|
OPK
|
██%
|
$865M
|
x
|
0,7x
|
|
Organogenesis Holdings Inc.
|
ORGO
|
██%
|
$305M
|
112,2x
|
1,3x
|
|
Orgenesis Inc.
|
ORGS
|
██%
|
$3M
|
x
|
x
|
|
Oric Pharmaceuticals, Inc.
|
ORIC
|
██%
|
$916M
|
x
|
2,2x
|
|
Oruka Therapeutics, Inc.
|
ORKA
|
██%
|
$3.87B
|
x
|
8,2x
|
|
Oramed Pharmaceuticals Inc.
|
ORMP
|
██%
|
$161M
|
2,5x
|
0,8x
|
|
Os Therapies Inc
|
OSTX
|
██%
|
$70M
|
x
|
x
|
|
Oncotelic Therapeutics, Inc.
|
OTLC
|
██%
|
$18M
|
x
|
2,0x
|
|
Ovid Therapeutics Inc.
|
OVID
|
██%
|
$484M
|
x
|
3,7x
|
|
One World Products, Inc.
|
OWPC
|
██%
|
$730K
|
x
|
x
|
|
Phibro Animal Health Corp
|
PAHC
|
██%
|
$1.62B
|
17,0x
|
4,5x
|
|
Prestige Consumer Healthcare Inc.
|
PBH
|
██%
|
$2.52B
|
13,5x
|
1,4x
|
|
Psyence Biomedical Ltd.
|
PBM
|
██%
|
$13M
|
x
|
x
|
|
Puma Biotechnology, Inc.
|
PBYI
|
██%
|
$381M
|
15,6x
|
3,0x
|
|
Pacira Biosciences, Inc.
|
PCRX
|
██%
|
$910M
|
177,1x
|
1,4x
|
|
Processa Pharmaceuticals, Inc.
|
PCSA
|
██%
|
$7M
|
x
|
2,9x
|
|
Procyon Corp
|
PCYN
|
██%
|
$2M
|
x
|
0,7x
|
|
Pds Biotechnology Corp
|
PDSB
|
██%
|
$70M
|
x
|
7,5x
|
|
Pepgen Inc.
|
PEPG
|
██%
|
$121M
|
x
|
0,8x
|
|
Pfizer Inc
|
PFE
|
██%
|
$146.14B
|
19,5x
|
1,6x
|
|
Precigen, Inc.
|
PGEN
|
██%
|
$1.49B
|
x
|
71,3x
|
|
Phathom Pharmaceuticals, Inc.
|
PHAT
|
██%
|
$966M
|
x
|
x
|
|
Phio Pharmaceuticals Corp.
|
PHIO
|
██%
|
$12M
|
x
|
0,8x
|
|
Pharvaris N.V.
|
PHVS
|
██%
|
$1.97B
|
x
|
x
|
|
Protokinetix, Inc.
|
PKTX
|
██%
|
$2M
|
x
|
8,4x
|
|
Plandai Biotechnology, Inc.
|
PLPL
|
██%
|
$4M
|
x
|
14,6x
|
|
Pliant Therapeutics, Inc.
|
PLRX
|
██%
|
$75M
|
x
|
0,4x
|
|
Polomar Health Services, Inc.
|
PMHS
|
██%
|
$13M
|
x
|
1,7x
|
|
Promis Neurosciences Inc.
|
PMN
|
██%
|
$88M
|
x
|
x
|
|
Pmv Pharmaceuticals, Inc.
|
PMVP
|
██%
|
$75M
|
x
|
0,7x
|
|
Purple Biotech Ltd.
|
PPBT
|
██%
|
$6M
|
x
|
x
|
|
Propanc Biopharma, Inc.
|
PPCB
|
██%
|
$2M
|
x
|
0,2x
|
|
Praxis Precision Medicines, Inc.
|
PRAX
|
██%
|
$9.19B
|
x
|
6,5x
|
|
Prf Technologies Ltd.
|
PRFX
|
██%
|
$2M
|
x
|
0,2x
|
|
Perrigo Co Plc
|
PRGO
|
██%
|
$1.62B
|
x
|
0,7x
|
|
Prelude Therapeutics Inc
|
PRLD
|
██%
|
$374M
|
x
|
5,5x
|
|
Prophase Labs, Inc.
|
PRPH
|
██%
|
$570K
|
x
|
0,1x
|
|
Proqr Therapeutics N.V.
|
PRQR
|
██%
|
$166M
|
x
|
x
|
|
Prothena Corp Public Ltd Co
|
PRTA
|
██%
|
$570M
|
x
|
1,8x
|
|
Ptc Therapeutics, Inc.
|
PTCT
|
██%
|
$6.11B
|
x
|
x
|
|
Protagonist Therapeutics, Inc
|
PTGX
|
██%
|
$6.38B
|
x
|
9,7x
|
|
Protagenic Therapeutics, Inc.\New
|
PTIX
|
██%
|
$2M
|
x
|
x
|
|
Palatin Technologies Inc
|
PTN
|
██%
|
$34M
|
x
|
3,0x
|
|
Palatin Technologies Inc
|
PTNT
|
██%
|
$17M
|
x
|
43,1x
|
|
Petros Pharmaceuticals, Inc.
|
PTPI
|
██%
|
$300K
|
0,1x
|
0,1x
|
|
Pulmatrix, Inc.
|
PULM
|
██%
|
$5M
|
x
|
1,2x
|
|
Provectus Biopharmaceuticals, Inc.
|
PVCT
|
██%
|
$27M
|
x
|
x
|
|
Palvella Therapeutics, Inc.
|
PVLA
|
██%
|
$1.74B
|
x
|
7,5x
|
|
Pyxis Oncology, Inc.
|
PYXS
|
██%
|
$172M
|
x
|
3,2x
|
|
Aixcrypto Holdings, Inc.
|
QLGN
|
██%
|
$8M
|
-1,3x
|
0,2x
|
|
Quoin Pharmaceuticals, Ltd.
|
QNRX
|
██%
|
$11M
|
x
|
1,2x
|
|
Quantum Biopharma Ltd.
|
QNTM
|
██%
|
$29M
|
x
|
x
|
|
Q32 Bio Inc.
|
QTTB
|
██%
|
$91M
|
2,7x
|
2,0x
|
|
Quantum Cyber N.V.
|
QUCY
|
██%
|
$5M
|
x
|
7,1x
|
|
Uniqure N.V.
|
QURE
|
██%
|
$1.74B
|
x
|
11,7x
|
|
Radiopharm Theranostics Ltd
|
RADX
|
██%
|
$32M
|
x
|
x
|
|
Rani Therapeutics Holdings, Inc.
|
RANI
|
██%
|
$121M
|
x
|
3,7x
|
|
Rapport Therapeutics, Inc.
|
RAPP
|
██%
|
$1.82B
|
x
|
3,9x
|
|
Rapt Therapeutics, Inc.
|
RAPT
|
██%
|
$1.56B
|
-0,4x
|
10,3x
|
|
Ultragenyx Pharmaceutical Inc.
|
RARE
|
██%
|
$2.57B
|
x
|
x
|
|
Rocket Pharmaceuticals, Inc.
|
RCKT
|
██%
|
$396M
|
x
|
1,7x
|
|
Arcus Biosciences, Inc.
|
RCUS
|
██%
|
$3.18B
|
x
|
6,1x
|
|
Dr Reddys Laboratories Ltd
|
RDY
|
██%
|
$11.05B
|
x
|
x
|
|
Regeneron Pharmaceuticals, Inc.
|
REGN
|
██%
|
$74.35B
|
16,8x
|
2,4x
|
|
Revelation Biosciences, Inc.
|
REVB
|
██%
|
$4M
|
x
|
0,3x
|
|
Rafael Holdings, Inc.
|
RFL
|
██%
|
$66M
|
x
|
0,8x
|
|
Regen Biopharma Inc
|
RGBP
|
██%
|
$110K
|
x
|
x
|
|
Regen Biopharma Inc
|
RGBPP
|
██%
|
$470K
|
x
|
x
|
|
Rigel Pharmaceuticals Inc
|
RIGL
|
██%
|
$479M
|
1,3x
|
1,2x
|
|
Relmada Therapeutics, Inc.
|
RLMD
|
██%
|
$768M
|
x
|
8,9x
|
|
Rallybio Corp
|
RLYB
|
██%
|
$76M
|
x
|
1,3x
|
|
Retrieve Medical Holdings, Inc.
|
RMHI
|
██%
|
$24M
|
x
|
x
|
|
Rockwell Medical, Inc.
|
RMTI
|
██%
|
$33M
|
x
|
0,9x
|
|
Avidity Biosciences, Inc.
|
RNA
|
██%
|
$206M
|
-12,2x
|
0,1x
|
|
Cartesian Therapeutics, Inc.
|
RNAC
|
██%
|
$247M
|
x
|
x
|
|
Transcode Therapeutics, Inc.
|
RNAZ
|
██%
|
$7M
|
x
|
4,7x
|
|
Rein Therapeutics, Inc.
|
RNTX
|
██%
|
$95M
|
x
|
5,6x
|
|
Renovorx, Inc.
|
RNXT
|
██%
|
$39M
|
x
|
7,2x
|
|
Roivant Sciences Ltd.
|
ROIV
|
██%
|
$20.27B
|
x
|
4,8x
|
|
Royalty Pharma Plc
|
RPRX
|
██%
|
$29.25B
|
35,4x
|
4,3x
|
|
Repare Therapeutics Inc.
|
RPTX
|
██%
|
$114M
|
-2,1x
|
1,0x
|
|
Rest Ez Inc.
|
RTEZ
|
██%
|
$1.93B
|
x
|
x
|
|
Rapid Therapeutic Science Laboratories, Inc.
|
RTSL
|
██%
|
$110K
|
1,9x
|
0,3x
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
RVPH
|
██%
|
$11M
|
x
|
1,3x
|
|
Rhythm Pharmaceuticals, Inc.
|
RYTM
|
██%
|
$6.45B
|
x
|
52,4x
|
|
Rezolute, Inc.
|
RZLT
|
██%
|
$307M
|
x
|
2,4x
|
|
Filana Therapeutics, Inc.
|
SAVA
|
██%
|
$101M
|
-1,9x
|
1,2x
|
|
Sunshine Biopharma Inc.
|
SBFM
|
██%
|
$5M
|
x
|
0,2x
|
|
Scienture Holdings, Inc.
|
SCNX
|
██%
|
$16M
|
x
|
0,2x
|
|
Scpharmaceuticals Inc.
|
SCPH
|
██%
|
$302M
|
-2,0x
|
-50,9x
|
|
Scorpius Holdings, Inc.
|
SCPX
|
██%
|
$610K
|
x
|
x
|
|
Scynexis Inc
|
SCYX
|
██%
|
$73M
|
x
|
1,5x
|
|
Stablecoin Development Corp
|
SDEV
|
██%
|
$43M
|
x
|
x
|
|
Schrodinger, Inc.
|
SDGR
|
██%
|
$971M
|
x
|
3,1x
|
|
Septerna, Inc.
|
SEPN
|
██%
|
$1.07B
|
x
|
2,8x
|
|
Serina Therapeutics, Inc.
|
SER
|
██%
|
$26M
|
x
|
x
|
|
Sagimet Biosciences Inc.
|
SGMT
|
██%
|
$476M
|
x
|
4,3x
|
|
Shuttle Pharmaceuticals Holdings, Inc.
|
SHPH
|
██%
|
$4M
|
x
|
1,7x
|
|
Siga Technologies Inc
|
SIGA
|
██%
|
$344M
|
17,0x
|
2,3x
|
|
Silo Pharma, Inc.
|
SILO
|
██%
|
$7M
|
x
|
1,0x
|
|
Sionna Therapeutics, Inc.
|
SION
|
██%
|
$1.98B
|
x
|
6,5x
|
|
Skinvisible, Inc.
|
SKVI
|
██%
|
$920K
|
x
|
x
|
|
Skye Bioscience, Inc.
|
SKYE
|
██%
|
$29M
|
x
|
1,4x
|
|
Sol-Gel Technologies Ltd.
|
SLGL
|
██%
|
$230M
|
x
|
10,1x
|
|
Silence Therapeutics Plc
|
SLN
|
██%
|
$329M
|
x
|
6,7x
|
|
Silence Therapeutics Plc
|
SLNCF
|
██%
|
$213M
|
x
|
2,9x
|
|
Soleno Therapeutics Inc
|
SLNO
|
██%
|
$2.74B
|
28,5x
|
5,5x
|
|
Salarius Pharmaceuticals, Inc.
|
SLRX
|
██%
|
$2M
|
-0,5x
|
0,4x
|
|
Sellas Life Sciences Group, Inc.
|
SLS
|
██%
|
$925M
|
x
|
13,0x
|
|
Summit Therapeutics Inc.
|
SMMT
|
██%
|
$14.03B
|
x
|
25,7x
|
|
Semnur Pharmaceuticals, Inc.
|
SMNR
|
██%
|
$1.38B
|
x
|
x
|
|
Syndax Pharmaceuticals Inc
|
SNDX
|
██%
|
$1.90B
|
x
|
45,7x
|
|
Soligenix, Inc.
|
SNGX
|
██%
|
$3M
|
x
|
1,0x
|
|
Sibannac, Inc.
|
SNNC
|
██%
|
$2M
|
x
|
x
|
|
Sensei Biotherapeutics, Inc.
|
SNSE
|
██%
|
$30M
|
x
|
1,6x
|
|
Sanofi
|
SNY
|
██%
|
$103.76B
|
x
|
x
|
|
Sonnet Biotherapeutics Holdings, Inc.
|
SONN
|
██%
|
$4M
|
-1,6x
|
29,5x
|
|
Spruce Biosciences, Inc.
|
SPRB
|
██%
|
$153M
|
x
|
3,6x
|
|
Scisparc Ltd.
|
SPRC
|
██%
|
$4M
|
x
|
x
|
|
Spero Therapeutics, Inc.
|
SPRO
|
██%
|
$144M
|
16,9x
|
2,5x
|
|
Ars Pharmaceuticals, Inc.
|
SPRY
|
██%
|
$868M
|
x
|
7,6x
|
|
Sarepta Therapeutics, Inc.
|
SRPT
|
██%
|
$2.11B
|
32,4x
|
1,4x
|
|
Stoke Therapeutics, Inc.
|
STOK
|
██%
|
$2.05B
|
x
|
5,2x
|
|
Shattuck Labs, Inc.
|
STTK
|
██%
|
$518M
|
x
|
5,4x
|
|
Supernus Pharmaceuticals, Inc.
|
SUPN
|
██%
|
$2.99B
|
x
|
2,8x
|
|
Savara Inc
|
SVRA
|
██%
|
$1.07B
|
x
|
5,3x
|
|
60 Degrees Pharmaceuticals, Inc.
|
SXTP
|
██%
|
$4M
|
x
|
1,2x
|
|
Synlogic, Inc.
|
SYBX
|
██%
|
$8M
|
x
|
0,6x
|
|
Spyre Therapeutics, Inc.
|
SYRE
|
██%
|
$5.92B
|
x
|
8,8x
|
|
Syros Pharmaceuticals, Inc.
|
SYRS
|
██%
|
$20K
|
-0,1x
|
-0,4x
|
|
Takeda Pharmaceutical Co Ltd
|
TAK
|
██%
|
$52.00B
|
x
|
x
|
|
Theravance Biopharma, Inc.
|
TBPH
|
██%
|
$876M
|
7,7x
|
3,0x
|
|
Alaunos Therapeutics, Inc.
|
TCRT
|
██%
|
$6M
|
x
|
2,9x
|
|
Telomir Pharmaceuticals, Inc.
|
TELO
|
██%
|
$89M
|
x
|
15,1x
|
|
Tenax Therapeutics, Inc.
|
TENX
|
██%
|
$301M
|
x
|
3,1x
|
|
Terns Pharmaceuticals, Inc.
|
TERN
|
██%
|
$6.12B
|
x
|
6,1x
|
|
Teva Pharmaceutical Industries Ltd
|
TEVA
|
██%
|
$41.60B
|
26,6x
|
5,1x
|
|
Teva Pharmaceutical Industries Ltd
|
TEVJF
|
██%
|
$38.09B
|
53,4x
|
5,3x
|
|
Tg Therapeutics, Inc.
|
TGTX
|
██%
|
$6.56B
|
14,2x
|
11,3x
|
|
Canton Strategic Holdings, Inc.
|
THAR
|
██%
|
$186M
|
x
|
30,2x
|
|
Talphera, Inc.
|
TLPH
|
██%
|
$45M
|
x
|
2,6x
|
|
Telix Pharmaceuticals Ltd
|
TLX
|
██%
|
$3.62B
|
x
|
x
|
|
Tango Therapeutics, Inc.
|
TNGX
|
██%
|
$3.13B
|
x
|
9,0x
|
|
Tonix Pharmaceuticals Holding Corp.
|
TNXP
|
██%
|
$180M
|
x
|
0,7x
|
|
Theriva Biologics, Inc.
|
TOVX
|
██%
|
$16M
|
x
|
1,0x
|
|
Tempest Therapeutics, Inc.
|
TPST
|
██%
|
$29M
|
x
|
4,3x
|
|
Traws Pharma, Inc.
|
TRAW
|
██%
|
$17M
|
-0,6x
|
1,5x
|
|
Entrada Therapeutics, Inc.
|
TRDA
|
██%
|
$263M
|
x
|
1,0x
|
|
Trevi Therapeutics, Inc.
|
TRVI
|
██%
|
$1.86B
|
x
|
10,8x
|
|
Trevena Inc
|
TRVN
|
██%
|
$260K
|
-1,3x
|
1,5x
|
|
Turn Therapeutics Inc.
|
TTRX
|
██%
|
$112M
|
x
|
23,8x
|
|
Tvardi Therapeutics, Inc.
|
TVRD
|
██%
|
$39M
|
x
|
2,7x
|
|
Travere Therapeutics, Inc.
|
TVTX
|
██%
|
$3.94B
|
x
|
39,9x
|
|
Therapeuticsmd, Inc.
|
TXMD
|
██%
|
$23M
|
x
|
0,9x
|
|
Tyra Biosciences, Inc.
|
TYRA
|
██%
|
$1.84B
|
x
|
7,1x
|
|
Unicycive Therapeutics, Inc.
|
UNCY
|
██%
|
$212M
|
x
|
7,0x
|
|
Upstream Bio, Inc.
|
UPB
|
██%
|
$493M
|
x
|
1,5x
|
|
Urogen Pharma Ltd.
|
URGN
|
██%
|
$1.43B
|
x
|
x
|
|
United Therapeutics Corp
|
UTHR
|
██%
|
$23.82B
|
18,5x
|
4,0x
|
|
Vaccinex, Inc.
|
VCNX
|
██%
|
$3M
|
x
|
x
|
|
Vera Therapeutics, Inc.
|
VERA
|
██%
|
$2.60B
|
x
|
5,2x
|
|
Veru Inc.
|
VERU
|
██%
|
$39M
|
-0,8x
|
2,1x
|
|
Sb Technology Holdings, Inc.
|
VGLS
|
██%
|
$450K
|
x
|
x
|
|
Vicapsys Life Sciences, Inc.
|
VICP
|
██%
|
$47M
|
x
|
x
|
|
Vincerx Pharma, Inc.
|
VINC
|
██%
|
$70K
|
-0,2x
|
0,0x
|
|
Viracta Therapeutics, Inc.
|
VIRX
|
██%
|
$390K
|
-0,2x
|
0,2x
|
|
Viking Therapeutics, Inc.
|
VKTX
|
██%
|
$3.65B
|
x
|
7,3x
|
|
Vanda Pharmaceuticals Inc.
|
VNDA
|
██%
|
$380M
|
x
|
1,4x
|
|
Verrica Pharmaceuticals Inc.
|
VRCA
|
██%
|
$138M
|
x
|
5,6x
|
|
Viridian Therapeutics, Inc.\De
|
VRDN
|
██%
|
$1.70B
|
x
|
2,7x
|
|
Vireo Growth Inc.
|
VREOF
|
██%
|
$348M
|
x
|
1,4x
|
|
Verona Pharma Plc
|
VRNA
|
██%
|
$73.55B
|
-185,1x
|
264,3x
|
|
Virpax Pharmaceuticals, Inc.
|
VRPX
|
██%
|
$160K
|
0,0x
|
-19,5x
|
|
Vertex Pharmaceuticals Inc / Ma
|
VRTX
|
██%
|
$109.24B
|
25,2x
|
5,6x
|
|
Verastem, Inc.
|
VSTM
|
██%
|
$427M
|
x
|
5,2x
|
|
Vistagen Therapeutics, Inc.
|
VTGN
|
██%
|
$26M
|
x
|
0,5x
|
|
Viatris Inc
|
VTRS
|
██%
|
$19.58B
|
x
|
1,3x
|
|
Vtv Therapeutics Inc.
|
VTVT
|
██%
|
$0.00M
|
-3,3x
|
-7,5x
|
|
Ventyx Biosciences, Inc.
|
VTYX
|
██%
|
$999M
|
-1,0x
|
5,2x
|
|
Vyne Therapeutics Inc.
|
VYNE
|
██%
|
$22M
|
x
|
0,8x
|
|
Whitehawk Therapeutics, Inc.
|
WHWK
|
██%
|
$187M
|
x
|
1,6x
|
|
Wave Life Sciences Ltd.
|
WVE
|
██%
|
$1.38B
|
x
|
2,7x
|
|
Xenetic Biosciences, Inc.
|
XBIO
|
██%
|
$7M
|
x
|
1,0x
|
|
Xbiotech Inc.
|
XBIT
|
██%
|
$76M
|
x
|
0,5x
|
|
Exicure, Inc.
|
XCUR
|
██%
|
$22M
|
x
|
5,5x
|
|
Xenon Pharmaceuticals Inc.
|
XENE
|
██%
|
$5.46B
|
x
|
4,1x
|
|
Xeris Biopharma Holdings, Inc.
|
XERS
|
██%
|
$1.11B
|
92,8x
|
85,6x
|
|
Xilio Therapeutics, Inc.
|
XLO
|
██%
|
$47M
|
x
|
1,3x
|
|
Xencor Inc
|
XNCR
|
██%
|
$937M
|
x
|
1,8x
|
|
Xoma Royalty Corp
|
XOMA
|
██%
|
$493M
|
15,5x
|
5,9x
|
|
Xoma Royalty Corp
|
XOMAO
|
██%
|
$312M
|
14,4x
|
3,6x
|
|
Xoma Royalty Corp
|
XOMAP
|
██%
|
$326M
|
15,1x
|
3,7x
|
|
Xtl Biopharmaceuticals Ltd
|
XTLB
|
██%
|
$6M
|
x
|
x
|
|
Zenas Biopharma, Inc.
|
ZBIO
|
██%
|
$1.21B
|
x
|
5,0x
|
|
Zai Lab Ltd
|
ZLAB
|
██%
|
$2.08B
|
x
|
3,1x
|
|
Zentalis Pharmaceuticals, Inc.
|
ZNTL
|
██%
|
$294M
|
x
|
1,4x
|
|
Zomedica Corp.
|
ZOMDF
|
██%
|
$132M
|
x
|
1,1x
|
|
Zoetis Inc.
|
ZTS
|
██%
|
$35.03B
|
13,3x
|
10,8x
|
|
Zevra Therapeutics, Inc.
|
ZVRA
|
██%
|
$640M
|
5,2x
|
3,1x
|
|
Zyversa Therapeutics, Inc.
|
ZVSA
|
██%
|
$2M
|
x
|
x
|
|
Zymeworks Inc.
|
ZYME
|
██%
|
$1.75B
|
-8,3x
|
6,5x
|
